Breast metastatic melanoma with multiple metastases: one case report

doi:10.3877/cma.j.issn.1674-0807.2025.05.011

Chinese Journal of Breast Disease(Electronic Edition) ›› 2025, Vol. 19 ›› Issue (05): 314-316. doi: 10.3877/cma.j.issn.1674-0807.2025.05.011

• Case Report • Previous Articles

Breast metastatic melanoma with multiple metastases: one case report

Lian Duan, Yan Wang, Jingruo Li^†()

Received:2024-11-21 Online:2025-10-01 Published:2025-11-11
Contact: Jingruo Li

Abstract

Lian Duan, Yan Wang, Jingruo Li. Breast metastatic melanoma with multiple metastases: one case report[J]. Chinese Journal of Breast Disease(Electronic Edition), 2025, 19(05): 314-316.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2025.05.011

https://zhrxbzz.cma-cmc.com.cn/EN/Y2025/V19/I05/314

Figures/Tables 5

References 18

［1］	Carvajal R，Maniar R. Extracutaneous melanoma ［J］. Hematol Oncol Clin North Am，2021，35（1）：85-98.
［2］	Tejera-Vaquerizo A，Nagore E，Meléndez JJ，et al. Chronology of metastasis in cutaneous melanoma：growth rate model ［J］. J Invest Dermatol，2012，132（4）：1215-1221.
［3］	Brodhead M，Woods RW，Fowler AM，et al. Multimodality imaging review of metastatic melanoma involving the breast ［J］. Curr Probl Diagn Radiol，2024，53（2）：289-296.
［4］	Bray F，Laversanne M，Sung H，et al. Global cancer statistics 2022：globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA Cancer J Clin，2024，74（3）：229-263.
［5］	Troxell ML. Merkel cell carcinoma，melanoma，metastatic mimics of breast cancer ［J］. Semin Diagn Pathol，2017，34（5）：479-495.
［6］	王若岩，贾琳娇，孔舒欣，等. 原发性肺癌乳腺转移一例［J/OL］. 中华乳腺病杂志（电子版），2024，18（4）：248-250.
［7］	张金堂，陈燕，袁华. 乳腺转移性恶性黑色素瘤超声及超声造影表现1例［J］. 中国临床医学影像杂志，2023，34（9）：670-672.
［8］	Gosman LM，Țăpoi DA，Costache M. Cutaneous melanoma：a review of multifactorial pathogenesis，immunohistochemistry，and emerging biomarkers for early detection and management ［J］. Int J Mol Sci，2023，24（21）：15881.
［9］	Pop AM，Monea M，Olah P，et al. The importance of immunohistochemistry in the evaluation of tumor depth of primary cutaneous melanoma ［J］. Diagnostics（Basel），2023，13（6）：1020.
［10］	Yang F，Ma J，Zhu D，et al. The role of S100A6 in human diseases：molecular mechanisms and therapeutic potential ［J］. Biomolecules，2023，13（7）：1139.
［11］	Zubovits J，Buzney E，Yu L，et al. HMB-45，S-100，NK1/c3，and MART-1 in metastatic melanoma ［J］. Hum Pathol，2004，35（2）：217-223.
［12］	Cheng L，Lopez-Beltran A，Massari F，et al. Molecular testing for braf mutations to inform melanoma treatment decisions：a move toward precision medicine ［J］. Mod Pathol，2018，31（1）：24-38.
［13］	Jalil A，Donate MM，Mattei J. Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma ［J］. Cancer Drug Resist，2024，7：42.
［14］	Leonardi GC，Falzone L，Salemi R，et al. Cutaneous melanoma：from pathogenesis to therapy（review）［J］. Int J Oncol，2018，52（4）：1071-1080.
［15］	Roskoski R Jr. Allosteric mek1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas ［J］. Pharmacol Res，2017，117：20-31.
［16］	Zaman A，Wu W，Bivona TG. Targeting oncogenic braf：past，present，and future ［J］. Cancers（Basel），2019，11（8）：1197.
［17］	Long GV，Stroyakovskiy D，Gogas H，et al. Dabrafenib and trametinib versus dabrafenib and placebo for val600 BRAF-mutant melanoma：a multicentre，double-blind，phase 3 randomised controlled trial ［J］. Lancet，2015，386（9992）：444-451.
［18］	Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer ［J］. J Exp Clin Cancer Res，2019，38（1）：255.

Please choose a citation manager

Content to export

Breast metastatic melanoma with multiple metastases: one case report

RichHTML

PDF (PC)

Knowledge